Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Outlook Therapeutics, Inc. (OTLK)
A side-by-side comparison of Corbus Pharmaceuticals Holdings, Inc. and Outlook Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$5.73HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
OTLK
Outlook Therapeutics, Inc.
$0.57HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
Total return — CRBP vs OTLK
growth of $100 · dividends reinvested · last 10yCRBP -97.2% (-30.1%/yr)OTLK -99.9% (-50.4%/yr)CRBP compounded faster over this window
Log scale — wide-divergence pair
CRBP OTLK
CRBP vs OTLK: by the numbers
- •OTLK is the larger company ($107M vs $106M market cap).
- •Both run net losses; CRBP's is the smaller (0.00% vs -4416.22% net margin).
Metrics side by side
Valuation
| Metric | CRBP | OTLK |
|---|---|---|
| P/B ratio | 1.04 | N/A |
Profitability
| Metric | CRBP | OTLK |
|---|---|---|
| Gross margin | 0.00% | 46.49% |
| Operating margin | 0.00% | -4744.25% |
| Net margin | 0.00% | -4416.22% |
| ROE | -99.67% | N/A |
| ROIC | -101.30% | -352.19% |
Growth (annualized)
| Metric | CRBP | OTLK |
|---|---|---|
| Total return CAGR (5Y) | -28.32% | -57.40% |
Frequently asked
- How have CRBP and OTLK total returns compared?
- Over the past 10 years, CRBP delivered -31.74% and OTLK delivered -50.38% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.